Invention Grant
- Patent Title: Chimpanzee adenoviral vector-based filovirus vaccines
-
Application No.: US15339225Application Date: 2016-10-31
-
Publication No.: US10584355B2Publication Date: 2020-03-10
- Inventor: Nancy J. Sullivan , Gary J Nabel , Clement Asiedu , Cheng Cheng , Alfredo Nicosia , Riccardo Cortese , Virginia Ammendola , Stefano Colloca
- Applicant: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES , GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: US MD Rockville BE Rixensart
- Assignee: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES,GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES,GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: US MD Rockville BE Rixensart
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Main IPC: C12N15/86
- IPC: C12N15/86 ; A61K39/12 ; C07K14/005 ; C12N7/00 ; A61K39/00
Abstract:
This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).
Public/Granted literature
- US20170044571A1 CHIMPANZEE ADENOVIRAL VECTOR-BASED FILOVIRUS VACCINES Public/Granted day:2017-02-16
Information query
IPC分类:
